| Evaluation of the Effect of Artesunate in Friedreich Ataxia (FA) (NCT04921930) | Institut National de la Santé Et de la Recherche Médicale, France | 2022-05-06 |
| Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma (NCT04848064) | John Reneau | 2022-05-06 |
| Kidney and Hematopoietic Cell Transplants Using a Regimen to Promote Hematopoietic Cell Engraftment (NCT04571203) | Stanford University | 2022-05-06 |
| NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors (NCT05354323) | NEC OncoImmunity AS | 2022-05-05 |
| P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma (NCT04960579) | Poseida Therapeutics, Inc. | 2022-05-05 |
| Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex (NCT05062070) | BioMendics, LLC | 2022-05-05 |
| Clinical Study to Investigate the Pharmacokinetics, Safety and Tolerability Following Single Administration of CHF6001 in Subjects With Mild, Moderate and Severe Liver Impairment in Comparison With Matched Healthy Control Subjects (NCT05373953) | Chiesi Farmaceutici S.p.A. | 2022-05-05 |
| Identifying Sleep Apnea Patients That Best Respond to Atomoxetine Plus Oxybutynin Therapy (NCT05550246) | Brigham and Women's Hospital | 2022-05-05 |
| THEMBA II T-Cell Vaccine: Vaccination With saRNA COVID-19 Vaccines (NCT05370040) | ImmunityBio, Inc. | 2022-05-05 |
| A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer (NCT05337137) | Bristol-Myers Squibb | 2022-05-05 |
| A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Rongliflozin in Type 2 Diabetic Subjects With Renal Impairment (NCT05374343) | Sunshine Lake Pharma Co., Ltd. | 2022-05-05 |
| A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis (NCT05371964) | Geron Corporation | 2022-05-04 |
| Anti-CD7 CAR-T Cell Therapy for Relapse and Refractory CD7 Positive T Cell Malignancies (NCT05290155) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2022-05-04 |
| Safety and Pharmacokinetics of Dioxidin, Solution for Topical and External Use, 0.25 mg/ml and Dioxidin, Solution for Infusion and External Use, 5 mg/ml in Healthy Volunteers (NCT05505097) | Valenta Pharm JSC | 2022-05-04 |
| Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors (NCT06128148) | Guangzhou JOYO Pharma Co., Ltd | 2022-05-04 |
| A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors (NCT05229497) | Akeso | 2022-05-04 |
| A Study to Learn More About How Much of the Study Treatment Elinzanetant (or BAY3427080) Gets Absorbed, How Safe it is and How it Affects the Body in Healthy Female and Male Participants (NCT05351892) | Bayer | 2022-05-04 |
| Phase 1/2a Study of ICT01 Plus Low Dose SC IL-2 in Patients With Advanced Solid Tumors (NCT05307874) | ImCheck Therapeutics, an Ipsen company | 2022-05-04 |
| Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions (NCT05536037) | Thomas Jefferson University | 2022-05-04 |
| Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects (NCT05363293) | Alzamend Neuro, Inc. | 2022-05-04 |
| Molecular Analysis of Intracanal Microbes After Chemomechanical Procedure and Root Canal Medication: A Randomized Controlled Trial (NCT06291623) | Mansoura University | 2022-05-03 |
| A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants. (NCT05329623) | Novartis Pharmaceuticals | 2022-05-03 |
| To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JT-001, JT-002 and JLP-2008 (NCT06165965) | Jeil Pharmaceutical Co., Ltd. | 2022-05-03 |
| R-MVST Cells for Treatment of Viral Infections (NCT05183490) | Columbia University | 2022-05-03 |
| HLX301 (TIGIT×PDL1 Bispecific) in Patients With Locally Advanced or Metastatic Solid Tumors (NCT05102214) | Shanghai Henlius Biotech | 2022-05-03 |
| HY-0102 Monotherapy in Patients With Locally Advanced/Metastatic Solid Tumours (NCT04914351) | Shanghai HyaMab Biotech Co.,Ltd. | 2022-05-03 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers (NCT05275465) | Huahui Health | 2022-05-03 |
| Non-invasive Vagal Nerve Stimulation in Alcohol Use Disorder (NCT05226130) | VA Office of Research and Development | 2022-05-02 |
| A Clinical Pharmacological Study of MT-3921 in Subjects With HTLV-1 Associated Myelopathy (HAM) (NCT05240612) | Tanabe Pharma Corporation | 2022-05-02 |
| Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors (NCT07121829) | Day One Biopharmaceuticals, Inc. | 2022-05-02 |
| A Study to Evaluate the Drug Levels of Cendakimab Delivered Subcutaneously in Healthy Participants (NCT05337345) | Bristol-Myers Squibb | 2022-05-02 |
| Evaluate the Pharmacokinetics, Safety and Tolerability of JT001 Tablets (NCT05355077) | Shanghai Vinnerna Biosciences Co., Ltd. | 2022-05-02 |
| Effects of LSD on Neuroplasticity in Healthy Subjects (NCT05177419) | University of Fribourg | 2022-05-02 |
| Study of Sulphoraphane in Chronic Kidney Disease (NCT05153174) | University of Rochester | 2022-05-02 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants (NCT05499260) | Shanghai Zhimeng Biopharma, Inc. | 2022-05-02 |
| Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers (NCT05353894) | Genoscience Pharma | 2022-05-02 |
| A Phase 1b Study of ONL1204 Ophthalmic Solution in Patients with Progressing Open Angle Glaucoma (NCT05160805) | ONL Therapeutics | 2022-05-02 |
| Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC (NCT05394415) | Jiangsu Cancer Institute & Hospital | 2022-05-01 |
| Mesenchymal Stromal Cells for the Treatment of Patients With COVID-19. (NCT05433298) | Paulo Brofman | 2022-05-01 |
| Comparison Between Pregabalin and Magnesium Sulfate in Hypotensive Anaesthesia (NCT05442931) | Minia University | 2022-05-01 |
| A Study of Oral Foralumab in Participants With Moderate to Severely Active Crohn's Disease (NCT05028946) | Tiziana Life Sciences LTD | 2022-05-01 |
| 68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies (NCT05506566) | First Affiliated Hospital of Fujian Medical University | 2022-05-01 |
| Feasibility of a Systems Approach for Alzheimer's Services Among Latinos Attending Primary Care Practices (NCT04418232) | University of Kansas Medical Center | 2022-05-01 |
| Mitoxantrone Hydrochloride Liposomes in Combination With GDP in Relapsed/Refractory PTCL (NCT05441761) | Peking Union Medical College Hospital | 2022-05-01 |
| Fecal Microbiota Transplantation for the Treatment of Non-Alcoholic Steatohepatitis (NCT03803540) | Puerta de Hierro University Hospital | 2022-05-01 |
| Efficacy and Tolerability of Tadalafil Versus Darifenacin in Management of Ureteric Stent-Related LUTS (NCT07206706) | Ain Shams University | 2022-05-01 |
| Sleep Disorders in Chronic Kidney Disease Patients (NCT05240261) | Assiut University | 2022-05-01 |
| Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function (NCT05328843) | PegBio Co., Ltd. | 2022-05-01 |
| CBD in Postmenopausal Women With Osteopenia (NCT05317013) | Canopy Growth Corporation | 2022-05-01 |
| A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128 (NCT05354102) | Biomica Ltd. | 2022-05-01 |
| Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors (NCT05231733) | SparX Biotech(Jiangsu) Co., Ltd. | 2022-05-01 |
| Study to Assess the Safety of MRx0029 or MRx0005 Compared to Placebo, in People With Parkinson's (NCT05832775) | 4D pharma plc | 2022-05-01 |
| Topical Insulin Versus Autologous Serum After Corneal Surgeries (NCT05331859) | Benha University | 2022-05-01 |
| Microbial Restoration in Inflammatory Bowel Diseases (NCT04970446) | St Vincent's Hospital Melbourne | 2022-05-01 |
| Safety, Tolerability and Pharmacokinetics of CMS121, a Drug Candidate for Alzheimer's Disease, in Healthy Subjects (NCT05318040) | Virogenics, Inc. | 2022-05-01 |
| A Clinical Study to Observe the Effectiveness and Safety of IBI310, Bevacizumab Combined With Sintilimab in the Treatment of Advanced Hepatocellular Carcinoma (NCT05363722) | Shanghai Zhongshan Hospital | 2022-05-01 |
| A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis (NCT05240300) | BiomX, Inc. | 2022-05-01 |
| A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above (NCT05365724) | China National Biotec Group Company Limited | 2022-05-01 |
| Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease (NCT05258682) | Mucpharm Pty Ltd | 2022-05-01 |
| Bioequivalence Study Between "DA-5215 Tab" and "DA-5215-R Tab" (NCT05376085) | Dong-A ST Co., Ltd. | 2022-05-01 |
| Novel Desensitization Kidney Transplantation (NCT05345717) | University of Chicago | 2022-05-01 |
| Role of Neutrophils and Electro-bioluminescence in the Rehabilitation (NCT06209229) | MIPO Clinic | 2022-05-01 |
| Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma (NCT05289492) | iTeos Therapeutics | 2022-05-01 |
| BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma) (NCT05299203) | West China Hospital | 2022-05-01 |
| 68Ga-FAP-RGD PET/CT : Dosimetry and Preliminary Clinical Translational Studies (NCT05515783) | First Affiliated Hospital of Fujian Medical University | 2022-05-01 |
| Topical Infliximab in Eyes With Penetrating Keratoplasty (NCT05180994) | Centre hospitalier de l'Université de Montréal (CHUM) | 2022-05-01 |
| A Study to Evaluate Effect of IN-A001 on Pharmacokinetics of Tacrolimus in Healthy Volunteers (NCT05353010) | HK inno.N Corporation | 2022-05-01 |
| SENL101 Autologous T Cell Injection in Adults With Relapsed or Refractory CD7+ Hematolymphoid Malignancies (NCT05398614) | Hebei Senlang Biotechnology Inc., Ltd. | 2022-05-01 |
| Clinical Trial of the TQB2930 Injection in Patients With Advanced Cancers (NCT05380882) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2022-05-01 |
| A Phase I Single- and Multiple- Ascending Dose and Food Effect Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7535 in Healthy Subjects (NCT05347758) | Shandong Suncadia Medicine Co., Ltd. | 2022-05-01 |
| Alectinib Pharmacokinetic in Patients With NSCLC (NCT05713006) | Instituto Nacional de Cancerologia de Mexico | 2022-05-01 |
| Intravenous Injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell Lymphoma (NCT05387226) | The First Affiliated Hospital of Bengbu Medical University | 2022-05-01 |
| Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer (NCT05261750) | PT. Prodia Stem Cell Indonesia | 2022-04-30 |
| A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in Adults (NCT05347498) | Jiangsu HengRui Medicine Co., Ltd. | 2022-04-30 |
| PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma (NCT05341193) | Sun Yat-sen University | 2022-04-30 |
| To Evaluate the Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Mild and Moderate Hepatic Impairment Compared to Participants With Normal Hepatic Function (NCT05404529) | Cerevel Therapeutics, LLC | 2022-04-29 |
| Clinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes (NCT05426798) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-04-29 |
| BAT7104 in Patients With Advanced Solid Tumours (NCT05200013) | Bio-Thera Solutions | 2022-04-29 |
| EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT) (NCT05444894) | Editas Medicine, Inc. | 2022-04-29 |
| A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy Volunteers (NCT05273775) | Jiangsu HengRui Medicine Co., Ltd. | 2022-04-29 |
| Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax (NCT05092373) | M.D. Anderson Cancer Center | 2022-04-29 |
| First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of EDI048 in Healthy Volunteers (NCT05275855) | Novartis Pharmaceuticals | 2022-04-29 |
| A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers (NCT05403554) | Light Chain Bioscience - Novimmune SA | 2022-04-29 |
| Effect of C21 on Forearm Blood Flow (NCT05277922) | Vicore Pharma AB | 2022-04-28 |
| ENSO 16 - Study in Healthy Subjects (NCT05457400) | Alpha Republic GmbH | 2022-04-28 |
| A Study to Learn About the Study Medicine (Called Lorlatinib) in People With Liver Dysfunction (NCT05224609) | Pfizer | 2022-04-28 |
| Safety of PUR001 Monotherapy in Patients With Advanced Solid Tumors (NCT05234853) | Purinomia Biotech, Inc. | 2022-04-28 |
| A Study to Evaluate the Pharmacokinetics After Administration of BR3003 and Co-administration of BR3003B and BR3003C. (NCT05411965) | Boryung Pharmaceutical Co., Ltd | 2022-04-28 |
| A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza (NCT05227001) | Pfizer | 2022-04-28 |
| An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness (NCT05381454) | University of California, Los Angeles | 2022-04-28 |
| A Clinical Study to Evaluate the Safety and Tolerability of JS012 in Advanced or Metastatic Solid Tumors (NCT05388279) | Shanghai Junshi Bioscience Co., Ltd. | 2022-04-28 |
| Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Efavirenz (NCT05330273) | Novartis Pharmaceuticals | 2022-04-28 |
| Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer (NCT05316129) | H. Lee Moffitt Cancer Center and Research Institute | 2022-04-28 |
| Safety and Efficacy of AM712 in Patients with NAMD (NCT05345769) | AffaMed Therapeutics Limited | 2022-04-28 |
| TST002 Intervenous Injection in Postmenopausal Women and Men With Reduced Bone Mineral Density (NCT05391776) | HJB (Hangzhou) Co., Ltd. | 2022-04-28 |
| A Study of HS-10382 in Patients With Chronic Myeloid Leukemia. (NCT05367700) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2022-04-28 |
| Clinical Trial of TQB2618 Injection Combined With TQB2450 Injection in Patients With Advanced Solid Tumors (NCT05645315) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-04-28 |
| Study of SUPLEXA in Patients With Metastatic Solid Tumours and Haematologic Malignancies (NCT05237206) | Alloplex Biotherapeutics Inc | 2022-04-28 |
| A Study to Evaluate the Safety, PK and PD of VIS171 in Participants (Healthy and With Autoimmune Disease) (NCT05418101) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2022-04-28 |
| A Study to Investigate the Efficacy and Safety of MS-553 in CLL/SLL (NCT05272813) | Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. | 2022-04-28 |